Frequently Asked Questions
The market is segmented based on , By Drug Type (Allergy and Respiratory Drugs, Cancer Therapies, Anti-Infectives, Cardiovascular Drugs, Gastrointestinal Drugs, Central Nervous System Drugs, Hormone Drugs, Urological Drugs, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) – Industry Trends and Forecast to 2029
.
The Global Pediatric Drugs Market size was valued at USD 117.20 USD Billion in 2021.
The Global Pediatric Drugs Market is projected to grow at a CAGR of 12.5% during the forecast period of 2022 to 2029.
The major players operating in the market include F. HoffmannLa Roche , Mylan N.V., Teva Pharmaceutical Industries , Sanofi, Pfizer , GlaxoSmithKline plc, Novartis AG, Zydus Cadila, AstraZeneca, Johnson & Johnson, Bayer AG, Sun Pharmaceutical Industries , Merck & Co., BristolMyers Squibb Company, Eli Lilly and Company, Cipla , Mallkrodt, Apotex , Hikma Pharmaceuticals PLC, Endo International plc.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
